Company Directory / Medical
PrivateFor profitMedicalChina
Addygene
Addy Gene is a gene editing technology firm that specializes in CRISPR/Cas research, development, services, and industrialization.
- Founded
- 2017 9 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $10M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
9 years old.
Reach
No web traffic ranking listed.
What it does
MedicalPharmaceutical
Funding, as listed
$10M currency not stated
- Rounds1
- LatestSeed, Aug 2024
- Investors3
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Addygene, field by field. Contact details are held but never shown.
The company
- Name
- Addygene
- Type
- For profit
- Status
- Private
- Founded
- 2017
- Industry
- Medical
- Categories
- Medical, Pharmaceutical
Where
- Country
- China
- Markets
- Asia-Pacific (APAC)
Size and reach
- Staff band
- 11-50
Funding, as listed
- Total
- 10,000,000 (currency not stated)
- Rounds
- 1
- Latest round
- Seed
- Latest round date
- Aug 2024
- Investors
- 3
- Listing status
- private
About this record
- Sources
- crunchbase,country:domain-tld
- Last imported
- Sept 2026
Companies like it
Medical in China.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 38,667 companies in China and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.